JiangSu WuZhong Pharmaceutical Development Co., Ltd.

    JiangSu WuZhong Pharmaceutical Development Co., Ltd.

    SSSE:600200
    0.29
    CNY
    0.00
    (0.00%)
    1,111.04P/E
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    5.96
    6.21
    4.88
    4.59
    5.82
    4.11
    2.38
    2.94
    2.62
    2.34
    2.92
    3.11
    2.27
    1.45
    Basic EPS, GAAP
    0.08
    0.08
    0.06
    0.08
    0.11
    0.19
    -0.4
    0.09
    -0.71
    0.03
    -0.11
    -0.1
    0.1
    - -
    Free Cash Flow per Basic Share
    0.49
    0.16
    -0.64
    -0.03
    0.81
    -0.04
    0.13
    -0.37
    -0.64
    0.56
    0.02
    -0.4
    -0.44
    -0.04
    Dividend per Share
    0.22
    0.18
    0.2
    0.22
    0.13
    0.09
    0.11
    0.07
    0.09
    0.08
    0.1
    0.09
    0.1
    0.08
    Book Value per Share
    1.27
    1.32
    1.36
    1.46
    1.52
    1.6
    1.16
    1.23
    0.53
    0.49
    0.43
    0.31
    0.42
    0.35
    Tangible Book Value per Share
    1.37
    1.47
    1.6
    2.45
    3.49
    3.28
    3.02
    2.91
    2.38
    2.23
    2.34
    2.12
    2.12
    2.04
    Basic Weighted Avg Shares
    624
    624
    628
    638
    686
    719
    714
    717
    713
    757
    693
    719
    705
    710
    Sales/Revenue/Turnover
    3,723
    3,875
    3,066
    2,928
    3,989
    2,960
    1,702
    2,110
    1,872
    1,775
    2,026
    2,240
    1,599
    1,028
    Operating Margin (%)
    2.89
    4.88
    5.47
    1.66
    1.81
    4.43
    -2.13
    -0.15
    -1.6
    -1.23
    -0.77
    -1.12
    8.01
    15.28
    Depreciation Expense
    40
    41
    47
    58
    70
    85
    89
    87
    83
    50
    48
    46
    50
    - -
    Net Income, GAAP
    47
    51
    41
    49
    72
    133
    -286
    65
    -506
    23
    -76
    -72
    70
    2
    Effective Tax Rate (%)
    34.57
    37.85
    34.68
    26.26
    - -
    26.31
    - -
    20.09
    - -
    47.4
    - -
    - -
    - -
    20.46
    Profit Margin (%)
    1.26
    1.3
    1.33
    1.68
    1.8
    4.5
    -16.78
    3.06
    -27.06
    1.28
    -3.76
    -3.21
    4.41
    0.16
    Working Capital
    478
    433
    627
    1,403
    1,085
    1,042
    627
    614
    1,084
    989
    874
    622
    948
    893
    LT Debt
    258
    235
    340
    426
    88
    88
    87
    115
    230
    168
    165
    141
    195
    195
    Total Equity
    1,008
    1,068
    1,139
    1,702
    2,968
    2,931
    2,408
    2,363
    1,852
    1,877
    1,824
    1,761
    1,889
    1,848
    Return on Invested Capital (%)
    2.86
    4.76
    4.06
    1.16
    - -
    2.44
    - -
    -0.08
    - -
    -0.36
    - -
    - -
    - -
    - -
    Return on Capital (%)
    2.59
    1.63
    1.78
    3.01
    - -
    7.65
    - -
    5.89
    - -
    3.44
    - -
    - -
    - -
    7.25
    Return on Common Equity (%)
    6.1
    6.25
    4.87
    5.5
    7.28
    12.12
    -28.8
    7.54
    -80.35
    6.07
    -22.84
    -27.69
    27.22
    0.65

    Capital Structure

    CNY

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    ST Debt
    1,452
    1,414
    1,373
    LT Borrowings
    181
    203
    182
    LT Finance Leases
    14
    13
    12
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    712
    712
    712
    Market Capitalization
    6,736
    3,757
    1,790

    Working Capital

    CNY

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    Total Current Assets
    2,753
    2,755
    2,651
    Cash, Cash Equivalents & STI
    1,152
    168
    110
    Accounts Receivable, Net
    1,296
    2,171
    2,140
    Inventories
    94
    95
    78
    Total Current Liabilities
    1,805
    1,865
    1,758
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    1,452
    1,414
    1,373
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CNY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    8.36%
    -3.86%
    7.24%
    Free Cash Flow
    -594.15%
    -454.71%
    8.28%
    Net Income, GAAP
    -191.4%
    -325.72%
    -197.97%
    Sales/Revenue/Turnover
    -3.3%
    -4.08%
    -28.64%
    Total Cash Common Dividend
    -3.62%
    5.67%
    -0.09%

    Quarterly Revenue

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    612
    489
    403
    737
    2,240
    2024
    425
    503
    441
    -49
    1,599
    2025
    317
    319
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.04
    - -
    - -
    - -
    -0.1
    2024
    0.01
    - -
    - -
    - -
    0.1
    2025
    -0.1
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.02
    - -
    - -
    - -
    0.09
    2024
    0.03
    - -
    - -
    - -
    0.1
    2025
    0.02
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business